What to do about AI in health?
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT CSAIL researchers develop advanced machine-learning models that outperform current methods in detecting pancreatic ductal adenocarcinoma.
Associate Professor Lydia Bourouiba and artist Argha Manna take readers through a series of discoveries in infectious disease.
A new MIT study identifies six systemic factors contributing to patient hazards in laboratory diagnostics tests.
Study of rigorous trial shows mixed results, suggests need to keep examining how nutrition can combat a pervasive disease.
Swallowing the device before a meal could create a sense of fullness, tricking the brain into thinking it’s time to stop eating.
By reevaluating existing data, researchers find the procedure is even more valuable than consensus had indicated.
Cancer nanomedicine was on display at the 2023 White House Demo Day.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.
Core-shell structures made of hydrogel could enable more efficient uptake in the body.
The new sensor measures heart and breathing rate from patients with sleep apnea and could also be used to monitor people at risk of opioid overdose.
The wearable device, designed to monitor bladder and kidney health, could be adapted for earlier diagnosis of cancers deep within the body.